Jefferies Financial Group Increases Teladoc Health (NYSE:TDOC) Price Target to $10.00

Teladoc Health (NYSE:TDOC - Free Report) had its target price hoisted by Jefferies Financial Group from $8.00 to $10.00 in a research report sent to investors on Tuesday, MarketBeat Ratings reports. They currently have a hold rating on the health services provider's stock.

Other analysts have also issued research reports about the stock. JPMorgan Chase & Co. dropped their price objective on shares of Teladoc Health from $16.00 to $9.00 and set a neutral rating on the stock in a research note on Monday, August 26th. Evercore ISI dropped their price target on shares of Teladoc Health from $14.00 to $10.00 and set an in-line rating on the stock in a research note on Tuesday, July 9th. Needham & Company LLC reiterated a hold rating on shares of Teladoc Health in a report on Thursday, August 1st. Oppenheimer lowered their target price on Teladoc Health from $21.00 to $17.00 and set an outperform rating for the company in a research note on Thursday, August 1st. Finally, DA Davidson cut their price target on Teladoc Health from $12.00 to $8.00 and set a neutral rating on the stock in a research note on Thursday, August 1st. Fifteen investment analysts have rated the stock with a hold rating and six have issued a buy rating to the company's stock. According to data from MarketBeat.com, the company currently has a consensus rating of Hold and an average price target of $12.31.

Teladoc Health Trading Up 11.6 %

Teladoc Health stock traded up $0.95 during trading on Tuesday, reaching $9.11. The company had a trading volume of 11,810,621 shares, compared to its average volume of 5,524,310. Teladoc Health has a 12-month low of $6.76 and a 12-month high of $22.54. The stock's 50 day moving average price is $8.05 and its two-hundred day moving average price is $11.02. The firm has a market capitalization of $1.56 billion, a price-to-earnings ratio of -6.44 and a beta of 0.90. The company has a debt-to-equity ratio of 0.66, a quick ratio of 1.62 and a current ratio of 1.66.

Teladoc Health (NYSE:TDOC - Get Free Report) last released its quarterly earnings data on Wednesday, July 31st. The health services provider reported ($0.28) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.36) by $0.08. Teladoc Health had a negative net margin of 38.54% and a negative return on equity of 10.25%. The company had revenue of $642.44 million during the quarter, compared to the consensus estimate of $649.34 million. As a group, equities analysts expect that Teladoc Health will post -0.73 earnings per share for the current fiscal year.

Insider Activity at Teladoc Health

In other Teladoc Health news, insider Vidya Raman-Tangella sold 3,857 shares of the firm's stock in a transaction on Friday, August 2nd. The stock was sold at an average price of $8.14, for a total value of $31,395.98. Following the sale, the insider now directly owns 33,667 shares in the company, valued at $274,049.38. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. In other Teladoc Health news, Director Thomas Mckinley bought 4,000 shares of the stock in a transaction that occurred on Thursday, September 12th. The shares were purchased at an average cost of $7.69 per share, for a total transaction of $30,760.00. Following the transaction, the director now directly owns 39,077 shares in the company, valued at $300,502.13. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, insider Vidya Raman-Tangella sold 3,857 shares of the business's stock in a transaction on Friday, August 2nd. The stock was sold at an average price of $8.14, for a total value of $31,395.98. Following the transaction, the insider now owns 33,667 shares of the company's stock, valued at approximately $274,049.38. The disclosure for this sale can be found here. Insiders sold 57,819 shares of company stock worth $442,204 in the last 90 days. 0.95% of the stock is currently owned by company insiders.

Institutional Investors Weigh In On Teladoc Health

A number of hedge funds and other institutional investors have recently modified their holdings of TDOC. Rubric Capital Management LP acquired a new stake in Teladoc Health in the second quarter worth approximately $45,267,000. Point72 Asset Management L.P. grew its holdings in Teladoc Health by 221.9% during the second quarter. Point72 Asset Management L.P. now owns 5,303,123 shares of the health services provider's stock worth $51,865,000 after acquiring an additional 3,655,436 shares during the period. Clearline Capital LP grew its holdings in Teladoc Health by 395.6% during the second quarter. Clearline Capital LP now owns 4,364,201 shares of the health services provider's stock worth $42,682,000 after acquiring an additional 3,483,665 shares during the period. Vanguard Group Inc. raised its position in Teladoc Health by 11.8% in the fourth quarter. Vanguard Group Inc. now owns 17,515,127 shares of the health services provider's stock worth $377,451,000 after acquiring an additional 1,855,480 shares in the last quarter. Finally, Dimensional Fund Advisors LP lifted its holdings in Teladoc Health by 25.0% in the 4th quarter. Dimensional Fund Advisors LP now owns 3,834,422 shares of the health services provider's stock valued at $82,636,000 after acquiring an additional 767,999 shares during the last quarter. 76.82% of the stock is currently owned by institutional investors.

Teladoc Health Company Profile

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.